GlassScriptPhysician profile
Babak Shabatian
NPI 1285675629
$3,697.39
in general payments reported to CMS, 2019-2025
28 companies · $964 in 2025
The $964 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $225 · 2021: $538 · 2022: $235 · 2023: $764 · 2024: $790 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068 · Long Term Medical Supply Or Device Loan: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.96 |
| Long Term Medical Supply Or Device Loan | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $510.19 | 2025 | Dextenza |
| Medtronic, INC. | $405.77 | 2021-2024 | Signia, Ligasure |
| Alcon Vision LLC | $298.18 | 2019-2024 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $292.21 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $288.68 | 2019-2023 | |
| Nova Eye, INC. | $227.48 | 2024-2025 | |
| Lumenis Be INC | $212.96 | 2023 | M22 |
| Bausch & Lomb Americas INC. | $191.58 | 2022-2024 | Envista Mx60 Iol, Envista Aspire Iol, Xiidra |
| Mallinckrodt Hospital Products INC. | $170.58 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $167.29 | 2024-2025 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| Sight Sciences, INC. | $113.53 | 2020-2024 | Omni Surgical System |
| Intuitive Surgical, INC. | $100.00 | 2021 | |
| Allergan, INC. | $89.14 | 2020-2022 | |
| Oyster Point Pharma, INC. | $73.93 | 2023-2025 | Tyrvaya |
| Harrow Eye, LLC | $71.31 | 2025 | Vevye, Tobradex St |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $62.73 | 2024-2025 | Tepezza |
| Rxsight INC | $54.12 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $50.04 | 2021-2023 | |
| Abbvie INC. | $46.08 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.51 | 2020-2021 | |
| New World Medical,INC. | $44.99 | 2024 | Streamline, Clearpath, Kahook Dual Blade |
| Aerie Pharmaceuticals, INC. | $44.92 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $33.70 | 2024 | Xdemvy |
| Bsn Medical INC | $30.87 | 2025 | |
| Shire North American Group INC | $22.94 | 2019 | |
| Beaver-Visitec International, INC. | $17.28 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Eyepoint US, INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Shabatian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.